Rallybio
NASDAQ: RLYB
Developing transformative therapies for devastating rare diseases.
Sector
Life SciencesCategory
TherapeuticsLocation
Farmington, CTInitial Investment
2020
Developing transformative therapies for devastating rare diseases.
Rallybio (NASDAQ: RLYB) is a biopharmaceutical company focused on identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders.